These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2966487)

  • 1. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
    Lind L; Wengle B; Ljunghall S
    Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of clodronate and calcitonin in hypercalcemia due to malignancy.
    Ljunghall S
    Recent Results Cancer Res; 1989; 116():40-5. PubMed ID: 2527399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
    Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
    Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clodronate treatment in patients with malignancy-associated hypercalcemia.
    Rastad J; Benson L; Johansson H; Knuutila M; Pettersson B; Wallfelt C; Akerström G; Ljunghall S
    Acta Med Scand; 1987; 221(5):489-94. PubMed ID: 2955674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP; Siris ES; Bilezikian JP; Baquiran DC; Shane E; Canfield RE
    Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
    Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
    Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE
    Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of calcitonin and clodronate in hypercalcaemia.
    Ljunghall S; Rastad J; Akerström G
    Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.
    Jung A
    Am J Med; 1982 Feb; 72(2):221-6. PubMed ID: 6460442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
    Rizzoli R; Buchs B; Bonjour JP
    Int J Cancer; 1992 Mar; 50(5):706-12. PubMed ID: 1531972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
    Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
    Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.
    Adami S; Bolzicco GP; Rizzo A; Salvagno G; Bertoldo F; Rossini M; Suppi R; Lo Cascio V
    Bone Miner; 1987 Aug; 2(5):395-404. PubMed ID: 2975514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
    Conte N; Di Virgilio R; Roiter I; Caberlotto L
    Tumori; 1985 Feb; 71(1):51-4. PubMed ID: 3157251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral diphosphonates for treating malignant hypercalcemia.
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia.
    Atula ST; Tähtelä RK; Nevalainen JI; Pylkkänen LH
    Acta Oncol; 2003; 42(7):735-40. PubMed ID: 14690159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypercalcemia of tumoral origin with two diphosphonates].
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1822-4. PubMed ID: 6792698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.